DE2212840A1 - Mittel zur Behandlung kardiovaskulaerer Stoerungen und pharmazeutische Praeparate zu seiner Anwendung - Google Patents

Mittel zur Behandlung kardiovaskulaerer Stoerungen und pharmazeutische Praeparate zu seiner Anwendung

Info

Publication number
DE2212840A1
DE2212840A1 DE19722212840 DE2212840A DE2212840A1 DE 2212840 A1 DE2212840 A1 DE 2212840A1 DE 19722212840 DE19722212840 DE 19722212840 DE 2212840 A DE2212840 A DE 2212840A DE 2212840 A1 DE2212840 A1 DE 2212840A1
Authority
DE
Germany
Prior art keywords
papaverine
adenosine
cardiovascular disorders
treatment
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19722212840
Other languages
German (de)
English (en)
Inventor
Mauvernay Roland Yves
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CT EUROP DE RECH S MAUVERNAY C
Original Assignee
CT EUROP DE RECH S MAUVERNAY C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CT EUROP DE RECH S MAUVERNAY C filed Critical CT EUROP DE RECH S MAUVERNAY C
Publication of DE2212840A1 publication Critical patent/DE2212840A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE19722212840 1971-03-16 1972-03-16 Mittel zur Behandlung kardiovaskulaerer Stoerungen und pharmazeutische Praeparate zu seiner Anwendung Pending DE2212840A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7109044A FR2129833B1 (US20100056889A1-20100304-C00004.png) 1971-03-16 1971-03-16

Publications (1)

Publication Number Publication Date
DE2212840A1 true DE2212840A1 (de) 1972-10-05

Family

ID=9073583

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722212840 Pending DE2212840A1 (de) 1971-03-16 1972-03-16 Mittel zur Behandlung kardiovaskulaerer Stoerungen und pharmazeutische Praeparate zu seiner Anwendung

Country Status (7)

Country Link
US (1) US3823234A (US20100056889A1-20100304-C00004.png)
JP (1) JPS5128686B1 (US20100056889A1-20100304-C00004.png)
AU (1) AU455699B2 (US20100056889A1-20100304-C00004.png)
DE (1) DE2212840A1 (US20100056889A1-20100304-C00004.png)
ES (1) ES400785A1 (US20100056889A1-20100304-C00004.png)
FR (1) FR2129833B1 (US20100056889A1-20100304-C00004.png)
GB (1) GB1336419A (US20100056889A1-20100304-C00004.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1447450A1 (en) * 2001-09-27 2004-08-18 Dnavec Research Inc. Method of regulating expression of gene carried on viral vector

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2257277B1 (US20100056889A1-20100304-C00004.png) * 1974-01-16 1978-02-03 Choay Sa
DE2717001C2 (de) * 1977-04-18 1984-06-20 Karl O. Helm Ag, 2000 Hamburg Arzneimittel mit antithrombotischer Wirkung
US4267182A (en) * 1979-01-16 1981-05-12 The United States Of America As Represented By The Secretary Of The Army Narcotic antagonists in the therapy of shock
DE3588205T2 (de) * 1985-09-24 1999-06-02 Item Dev Ab Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten
US5104859A (en) * 1985-09-24 1992-04-14 Solimedco Aktiebolag Continuous administration of adenosine to reduce pulmonary vascular resistance
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4923851A (en) * 1987-12-29 1990-05-08 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US5665731A (en) * 1995-06-07 1997-09-09 Hennessey; Richard K. Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131923C (US20100056889A1-20100304-C00004.png) * 1966-02-25
GB1186863A (en) * 1966-06-06 1970-04-08 Prodotti Antibiotici Spa Salts of 6-Phosphogluconic Acid and Pharmaceutical Compositions containing 6-Phosphogluconic Acid or Salts thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1447450A1 (en) * 2001-09-27 2004-08-18 Dnavec Research Inc. Method of regulating expression of gene carried on viral vector
EP1447450A4 (en) * 2001-09-27 2005-02-16 Dnavec Research Inc METHOD FOR REGULATING THE EXPRESSION OF A GENERATED GENE ON A VIRAL VECTOR

Also Published As

Publication number Publication date
AU4000272A (en) 1973-09-20
AU455699B2 (en) 1974-11-07
FR2129833A1 (US20100056889A1-20100304-C00004.png) 1972-11-03
JPS5128686B1 (US20100056889A1-20100304-C00004.png) 1976-08-20
GB1336419A (en) 1973-11-07
US3823234A (en) 1974-07-09
ES400785A1 (es) 1976-02-01
FR2129833B1 (US20100056889A1-20100304-C00004.png) 1974-08-02

Similar Documents

Publication Publication Date Title
DE2128674C2 (de) Clathratverbindungen von Prostaglandinen oder ihren Analogen mit Cyclodextrin, Verfahren zu deren Herstellung und diese Clathratverbindungen enthaltende pharmazeutische Zubereitungen
DE69434560T2 (de) Kombination eines Angiotensin-II antagonistisch wirkenden Benzimidazols mit Manidipin zur Behandlung von Bluthochdruck
DE3827974A1 (de) Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
DE3886075T2 (de) Verwendung von Metformin zur Herstellung von Arzneimitteln.
EP0040325B1 (de) Verwendung von Adenosinderivaten zur Herstellung eines Psychopharmakons
DE19523502A1 (de) Kappa-Opiatagonisten für entzündliche Darmerkrankungen
DE2212840A1 (de) Mittel zur Behandlung kardiovaskulaerer Stoerungen und pharmazeutische Praeparate zu seiner Anwendung
DE68910287T2 (de) Castanospermin-ester zur Hemmung der Tumormetastasierung.
DE2513940A1 (de) Pharmazeutische zubereitung
EP0317855B1 (de) Pharmazeutische Präparate
EP0607777A2 (de) Verwendung von Leflunomid zur Herstellung von Interleukin 8
KR0133555B1 (ko) 5-플루오로우라실계 화합물에 기인한 염증의 발생을 억제할 수 있는 비-주사제 형태의 항암조성물
DE69814089T2 (de) Verwendung von einem draflazin analog zur schmerzbehandlung
EP0471388B1 (de) Mittel zur Behandlung der Herzinsuffizienz
DE3425466A1 (de) Synergistisches arzneimittelpraeparat zur behandlung von leberkrankheiten
DE3141970C2 (US20100056889A1-20100304-C00004.png)
DE19815411A1 (de) Thermogenese stimulierend wirksame Arzneimittel
DE2357074A1 (de) Gefaesserweiterndes und sympatholytisches arzneimittel
JPS6061527A (ja) 抗不整脈効力を有する医薬組成物
DE3904795C2 (de) Pharmazeutisches Präparat und dessen Verwendung
DE4217396A1 (de) Metrifonat enthaltendes Arzneimittel
DE3213579C2 (US20100056889A1-20100304-C00004.png)
CH672069A5 (US20100056889A1-20100304-C00004.png)
EP0019586A1 (de) Neue antithrombotische Kombinationspräparate
EP0281608A1 (de) Hydroxyindolderivat.

Legal Events

Date Code Title Description
OHN Withdrawal